BLU实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (29 Jun 2023 @ 03:59):

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications...

Stats
今日成交量	2.84M
平均成交量	5.38M
市值	1.87B
EPS	$0 ( 2024-03-19 )
下一个收益日期	( $0 ) 2024-05-10
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-20.20
ATR14	$0.119 (0.81%)

音量相关性

長: 0.19 (neutral)

短: 0.64 (weak)

Signal:(78.88) Neutral

BELLUS Health Inc 相关性

10 最正相关
SRRA	0.976
SCPL	0.973
DTSS	0.968
CYCN	0.966
NISN	0.961
BWC	0.959
MEDP	0.958
HCSG	0.955
TESS	0.955
MNTV	0.954

10 最负相关
QDEL	-0.976
LIZI	-0.953
CYAN	-0.95
SSRM	-0.943
JCTCF	-0.943
CRUS	-0.942
BRQS	-0.941
MTEX	-0.939
VRAY	-0.935
CFBK	-0.934

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

BELLUS Health Inc 相关性 - 货币/商品

0.36
( neutral )

0.75
( moderate )

0.04
( neutral )

0.20
( neutral )

-0.47
( neutral )

-0.74
( moderate negative )

BELLUS Health Inc 财务报表

Annual	2022
营收:	$16 000.00
毛利润:	$-3.51B (-21 967 104.08 %)
EPS:	$-0.660

FY	2022
营收:	$16 000.00
毛利润:	$-3.51B (-21 967 104.08 %)
EPS:	$-0.660

FY	2021
营收:	$16 000.00
毛利润:	$0.00 (0.00 %)
EPS:	$-1.207

FY	2020
营收:	$15 000.00
毛利润:	$0.00 (0.00 %)
EPS:	$-0.540

Financial Reports:

No articles found.

BELLUS Health Inc

BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. The company was incorporated in 1993 and is based in Laval, Canada.